Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.

Karaiskos D, Tzavellas E, Ilias I, Liappas I, Paparrigopoulos T.

Int J Clin Pract. 2013 Mar;67(3):257-60. doi: 10.1111/ijcp.12112.

PMID:
23409693
2.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
3.

Depression treatment and its impact upon the quality of life in patients with diabetes type 2 - the Croatian study.

Filipcić I, Margetić B, Simunović I, Jakovljević M.

Psychiatr Danub. 2010 Jun;22(2):231-5.

4.

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.

Demyttenaere K, Corruble E, Hale A, Quera-Salva MA, Picarel-Blanchot F, Kasper S.

CNS Spectr. 2013 Jun;18(3):163-70. doi: 10.1017/S1092852913000060. Epub 2013 Mar 11.

PMID:
23472671
5.

Agomelatine: an antidepressant without deterioration of sexual response.

Sapetti A.

J Sex Marital Ther. 2012;38(2):190-7. doi: 10.1080/0092623X.2011.613095.

PMID:
22390531
6.

Clinical efficacy of agomelatine in depression: the evidence.

den Boer JA, Bosker FJ, Meesters Y.

Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S21-4.

PMID:
16436936
7.

Sertraline effectiveness and safety in depressed oncological patients.

Torta R, Siri I, Caldera P.

Support Care Cancer. 2008 Jan;16(1):83-91. Epub 2007 Sep 14.

PMID:
17874143
8.

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D.

J Clin Psychiatry. 2001 Jan;62(1):24-9.

PMID:
11235924
9.

Major depressive disorder, anhedonia and agomelatine: an open-label study.

Di Giannantonio M, Di Iorio G, Guglielmo R, De Berardis D, Conti CM, Acciavatti T, Cornelio M, Martinotti G.

J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):109-14.

PMID:
21382280
10.

An open, baseline controlled evaluation of sertraline safety and efficacy in the treatment of depression in Thai patients.

SESS Group (Sertraline Efficacy and Safety Study Group).

J Med Assoc Thai. 2001 Jan;84(1):54-62.

PMID:
11281500
11.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
13.

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial.

Kang R, He Y, Yan Y, Li Z, Wu Y, Guo X, Liang Z, Jiang J.

Neuropsychiatr Dis Treat. 2015 May 27;11:1307-11. doi: 10.2147/NDT.S85711. eCollection 2015.

14.

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.

Psychosom Med. 1997 May-Jun;59(3):241-50.

PMID:
9178335
15.

Agomelatine treatment of major depressive disorder.

Dolder CR, Nelson M, Snider M.

Ann Pharmacother. 2008 Dec;42(12):1822-31. doi: 10.1345/aph.1L296. Epub 2008 Nov 25. Review.

PMID:
19033480
16.

Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study.

Stein DJ, Ahokas A, Albarran C, Olivier V, Allgulander C.

J Clin Psychiatry. 2012 Jul;73(7):1002-8. doi: 10.4088/JCP.11m07493.

PMID:
22901350
17.

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.

Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M.

Curr Med Res Opin. 2007 Feb;23(2):245-50.

PMID:
17288677
18.

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

Arch Gen Psychiatry. 2006 May;63(5):521-9.

PMID:
16651509
19.

Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.

Stein DJ, Ahokas AA, de Bodinat C.

J Clin Psychopharmacol. 2008 Oct;28(5):561-6. doi: 10.1097/JCP.0b013e318184ff5b.

PMID:
18794654
20.

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine.

Goodwin GM, Boyer P, Emsley R, Rouillon F, de Bodinat C.

Int Clin Psychopharmacol. 2013 Jan;28(1):20-8. doi: 10.1097/YIC.0b013e32835b0814.

PMID:
23151774

Supplemental Content

Support Center